BWAY Brainsway Ltd. ADRs

BrainsWay is dedicated to developing and providing advanced technology solutions for the treatment of a variety of brain disorders. The company was established in 2003, and became a public company traded on the Tel-Aviv Stock Exchange in January 2007.  This is an ADR of a company whose stock trades outside of the U.S. as the symbol IT:BRIN.

$1.87  +0.02 (1.08%)
As of 03/24/2023 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Information Technology
Industry:  Diagnostics & Research
Index country:  Israel
Country of incorporation:  
IPO date:  04/17/2019
Outstanding shares:  16,541,246
Average volume:  22,524
Market cap:   $30,601,305
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%